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Abstract 
Three different experiments were performed to evaluate and 
compare the efficacy of some drugs used in the veterinary field in 
the Sudan and their economic impact. 
 In experiment 1 nine goats naturally infected with 
pneumonia caused by different types of bacteria were divided into 
three equal groups, group 1 received treatment with 
oxytetracycline 5% at the recommended dosage rate of 10 mg/kg 
body weight daily for 5 consecutive days, group 2 received 
treatment with a single dose of oxytetracycline 20% at the 
recommended dosage rate of 20 mg/kg body weight daily, group 3 
was left untreated as control. Body temperature and respiratory 
rate were taken, cough and nasal discharge were observed daily 
throughout the period of study. Whole blood samples were taken 
at weekly intervals for haemoglobin estimation and differential 
count of white blood cells. After 21 days all animals were sacrified, 
lungs were observed for gross appearance and samples from 
them were taken for microbiological culture and histopatholgical 
examination. 
In experiment 2 nine goats naturally infected with internal 
parasites belong to the genus Tricostrongylus were divided into 
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three equal groups, group 1 received treatment with albendazole 
2.5%, group 2 received treatment with albendazole 5%, group 3 
received treatment with albendazole 10% at the recommended 
dosage rate of 7.5 mg/kg body weight. Faecal samples and whole 
blood samples were taken at weekly intervals for four weeks for 
egg count and haemoglobin estimation, respectively. Body weights 
were recorded weekly for body weight gain. 
In experiment 3 six goats naturally infected with mastitis 
caused by Actinomyces pyogenes were used, two goats received 
treatment with neomastipra intramammary infusion every 12 hours 
for 3 days, two goats received treatment with terrexine 
intramammary infusion twice daily for three consecutive days and 
two goats was left as untreated control. Milk samples were taken 
at days 7 and 14 after treatment for microbiological culture. 
This study revealed that oxytetracycline 20% is more 
economical in comparison with Oxytetracycline 5%. Also the 
anthelmintic albendazole 10% is more economical compared with 
albendazole 5% and albendazole 2.5%. The study revealed that 
the treatment with neomastipra intramammary infusion is more 
economical than with terrexine intramammary infusion. 
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 اﻟﺨﻼﺻﺔ
أﺟﺮﻳﺖ ﺛﻼث ﺗﺠﺎرب ﻣﺨﺘﻠﻔﺔ ﻟﺘﻘﻴﻴﻢ و ﻣﻘﺎرﻧﺔ ﻓﻌﺎﻟﻴﺔ ﺑﻌﺾ اﻷدوﻳﺔ اﻟﻤѧﺴﺘﺨﺪﻣﺔ ﻓѧﻲ اﻟﺤﻘѧﻞ 
ﻓѧﻰ اﻟﺘﺠﺮﺑѧﺔ اﻷوﻟѧﻰ أﺳѧﺘﺨﺪﻣﺖ ﺗѧﺴﻊ ﻣﻌѧﺰات . اﻟﺒﻴﻄѧﺮى ﻓѧﻰ اﻟѧﺴﻮدان و اﻟﻤѧﺮدود اﻻﻗﺘѧﺼﺎدى ﻟﻬѧﺎ
  . ﻣﺼﺎﺑﺔ ﻃﺒﻴﻌﻴﺎ اﻟﺮﺋﺔ اﻟﻤﺴﺒﺒﺔ ﺑﺄﻧﻮاع ﻣﺨﺘﻠﻔﺔ ﻣﻦ اﻟﺒﻜﺘﻴﺮﻳﺎ ، ﻗﺴﻤﺖ اﻟﻰ ﺛﻼث ﻣﺠﻤﻮﻋﺎت ﻣﺘﺴﺎوﻳﺔ
ﺑѧﺎﻟﺤﻘﻦ داﺧѧﻞ اﻟﻌѧﻀﻞ % 5ﻤﺠﻤﻮﻋѧﺔ اﻷوﻟѧﻰ ﺗﻠﻘѧﺖ اﻟﻌѧﻼج ﺑﻌﻘѧﺎر أوآѧﺴﻰ ﺗﺘﺮاﺳѧﻴﻜﻠﻴﻦ اﻟ
اﻟﻤﺠﻤﻮﻋѧﺔ . آﺠﻢ ﻣﻦ وزن اﻟﺤﻴﻮان ﻳﻮﻣﻴﺎ ﻟﻤѧﺪة ﺧﻤѧﺴﺔ أﻳѧﺎم / ﻣﻠﺠﻢ 01ﺑﺎﻟﺠﺮﻋﺔ اﻟﻤﻮﺻﻮﻓﺔ وﻗﺪرهﺎ 
ﺑѧﺎﻟﺤﻘﻦ داﺧѧﻞ اﻟﻌѧﻀﻞ ﺑﺎﻟﺠﺮﻋѧﺔ اﻟﻤﻮﺻѧﻮﻓﺔ % 02ﺗﻠﻘﺖ اﻟﻌﻼج ﺑﻌﻘﺎر أوآѧﺴﻰ ﺗﺘﺮاﺳѧﻴﻜﻠﻴﻦ  اﻟﺜﺎﻧﻴﺔ
وزن اﻟﺤﻴѧﻮان ﺟﺮﻋѧﺔ واﺣѧﺪة و اﻟﻤﺠﻤﻮﻋѧﺔ اﻟﺜﺎﻟﺜѧﺔ ﺗﺮآѧﺖ ﺑѧﺪون ﻋѧﻼج آﺠﻢ ﻣﻦ / ﻣﻠﺠﻢ 02وﻗﺪرهﺎ 
ﺗѧﻢ أﺧѧﺬ ﺣѧﺮارة اﻟﻤѧﺴﺘﻘﻴﻢ وﻣﻌѧﺪل اﻟﺘѧﻨﻔﺲ ﺗѧﻢ أﺧѧﺬهﻤﺎ وﺗﻤѧﺖ ﻣﻼﺣﻈѧﺔ اﻟﻜﺤѧﺔ واﻻﻓѧﺮازات .آﻤﺮﺟѧﻊ
أﺧѧﺬت ﻋﻴﻨѧﺎت اﻟѧﺪم اﻟﻜﺎﻣѧﻞ ﻟﺘﻘѧﺪﻳﺮ .اﻷﻧﻔﻴﺔ ﻳﻮﻣﻴѧﺎ ﻃѧﻮال ﻣѧﺪة اﻟﺘﺠﺮﺑѧﺔ و اﻟﺒѧﺎﻟﻎ ﻗѧﺪرهﺎ ﺛﻼﺛѧﺔ أﺳѧﺎﺑﻴﻊ 
 ﻳﻮم ذﺑﺤﺖ آѧﻞ اﻟﺤﻴﻮاﻧѧﺎت و ﺗѧﻢ 12ﺑﻌﺪ . ﻞ ﻟﻜﺮﻳﺎت اﻟﺪم اﻟﺒﻴﻀﺎء اﻟﻬﻴﻤﻮﻏﻠﻮﺑﻴﻦ واﺟﺮاء اﻟﻌﺪ اﻟﻜﺎﻣ 
  .ﻣﻼﺣﻈﺔ اﻟﻤﻈﻬﺮ اﻟﻌﻴﺎﻧﻰ ﻟﻠﺮﺋﺔ وأﺧﺪت ﻋﻴﻨﺎت ﻣﻨﻬﺎ ﻟﻠﺘﺸﺮﻳﺢ اﻟﻤﺮﺿﻰ و اﻟﺰرع اﻟﺠﺮﺛﻮﻣﻰ
ﻓﻰ اﻟﺘﺠﺮﺑﺔ اﻟﺜﺎﻧﻴѧﺔ أﺳѧﺘﺨﺪﻣﺖ ﺗѧﺴﻊ ﻣﻌѧﺰات ﻣѧﺼﺎﺑﺔ ﻃﺒﻴﻌﻴѧﺎ ﺑﺪﻳѧﺪان داﺧﻠﻴѧﺔ ﺗﻨﺘﻤѧﻰ ﻟﺠѧﻨﺲ 
اﻟﻤﺠﻤﻮﻋﺔ اﻷوﻟѧﻰ ﺗﻠﻘѧﺖ اﻟﻌѧﻼج ﺑﻌﻘѧﺎر . ﺗﺮاﻳﻜﻮﺳﺘﺮوﻧﻘﻴﻠﺲ، ﻗﺴﻤﺖ اﻟﻰ ﺛﻼث ﻣﺠﻤﻮﻋﺎت ﻣﺘﺴﺎوﻳﺔ 
و، اﻟﻤﺠﻤﻮﻋѧﺔ اﻟﺜﺎﻟﺜѧﺔ % 5، اﻟﻤﺠﻤﻮﻋѧﺔ اﻟﺜﺎﻧﻴѧﺔ ﺗﻠﻘѧﺖ اﻟﻌѧﻼج ﺑﻌﻘѧﺎر أﻟﺒﻨѧﺪازول % 5.2أﻟﺒﻨѧﺪازول 
آﺠѧѧﻢ ﻣѧѧﻦ وزن / ﻣﻠﺠѧѧﻢ5.7ﺑﺎﻟﺠﺮﻋѧѧﺔ اﻟﻤﻮﺻѧѧﻮﻓﺔ وﻗѧѧﺪرهﺎ % 01ﺗﻠﻘѧѧﺖ اﻟﻌѧѧﻼج ﺑﻌﻘѧѧﺎر أﻟﺒﻨѧѧﺪازول 
أرﺑﻌѧﺔ أﺳѧﺎﺑﻴﻊ ﻟﻌѧﺪ اﻟﺒﻴѧﻮض و أﺧﺬت ﻋﻴﻨﺎت اﻟﺒѧﺮاز وﻋﻴﻨѧﺎت اﻟѧﺪم اﻟﻜﺎﻣѧﻞ أﺳѧﺒﻮﻋﻴﺎ ﻟﻤѧﺪة . اﻟﺤﻴﻮان
  .آﺬﻟﻚ وزﻧﺖ اﻟﺤﻴﻮاﻧﺎت أﺳﺒﻮﻋﻴﺎ ﻟﻤﻌﺮﻓﺔ اﻟﺰﻳﺎدة ﻓﻰ اﻟﻮزن. ﺗﻘﺪﻳﺮ اﻟﻬﻴﻤﻮﻏﻠﺒﻴﻦ ﻋﻠﻰ اﻟﺘﻮاﻟﻰ
ﻓѧѧﻰ اﻟﺘﺠﺮﺑѧѧﺔ اﻟﺜﺎﻟﺜѧѧﺔ أﺳѧѧﺘﺨﺪﻣﺖ ﺳѧѧﺖ  ﻣﻌѧѧﺰات ﻣѧѧﺼﺎﺑﺔ ﻃﺒﻴﻌﻴѧѧﺎ ﺑﻤѧѧﺮض اﻟﺘﻬѧѧﺎب اﻟѧѧﻀﺮع 
ﺮا   ﻣѧﺎﻋﺰ ﺗﻠﻘѧﺖ اﻟﻌѧﻼج ﺑﻤﺴﺘﺤѧﻀﺮ ﻧﻴﻮﻣѧﺴﺘﻴﺒ 2اﻟﻤﺴﺒﺐ ﺑﻮاﺳﻄﺔ ﺑﻜﺘﻴﺮﻳﺎ اآﺘﻴﻨﻮﻣﻴﺴﻴﺲ ﺑﻴѧﻮﺟﻴﻨﺲ، 
 ﻣﺎﻋﺰ ﺗﻠﻘﺖ اﻟﻌﻼج ﺑﻤﺴﺘﺤﻀﺮ ﺗﻴﺮآﺴﻴﻦ  2أﻳﺎم ﻣﺘﺘﺎﻟﻴﺔ داﺧﻞ اﻟﻀﺮع  ،   ﺳﺎﻋﺔ ﻟﻤﺪة ﺛﻼﺛﺔ 21آﻞ 
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أﺧѧﺬت . ﻣѧﺎﻋﺰ ﺗﺮآѧﺖ ﻣѧﻦ ﻏﻴѧﺮ ﻋѧﻼج2أﻳѧﺎم ﻣﺘﺘﺎﻟﻴѧﺔ داﺧѧﻞ اﻟѧﻀﺮع و   ﺳѧﺎﻋﺔ ﻟﻤѧﺪة ﺛﻼﺛѧﺔ21آѧﻞ 
  . ﻳﻮم ﺑﻌﺪ اﻟﻌﻼج ﻟﻠﺰرع اﻟﺠﺮﺛﻮﻣﻰ41 و 7ﻋﻴﻨﺎت اﻟﻠﺒﻦ ﺑﻌﺪ 
ﻦ ﻃﻮﻳѧﻞ اﻟﻤﻔﻌѧﻮل ﻳﻌﺘﺒѧﺮ اﻗﺘѧﺼﺎدﻳﺎ ﻣﻘﺎرﻧѧﺔ  أوﺿﺤﺖ هѧﺬﻩ اﻟﺪراﺳѧﺔ أن أوآѧﺴﻰ ﺗﺘﺮاﺳѧﻴﻜﻠﻴ 
اﺿѧﺎﻓﺔ اﻟѧﻰ أﻧѧﻪ ﻳﻌﻄѧﻰ ﻣѧﺮة واﺣѧﺪة، وآѧﺬﻟﻚ ﻣѧﻀﺎد اﻟﺪﻳѧﺪان أﻟﺒﻨѧﺪازول % 5أوآѧﺴﻰ ﺗﺘﺮاﺳѧﻴﻜﻠﻴﻦ 
أﻣѧѧѧﺎ ﻣѧѧѧﺮاهﻢ اﻟѧѧѧﻀﺮع %. 5.2و أﻟﺒﻨѧѧѧﺪازول % 5ﻳﻌﺘﺒѧѧѧﺮ اﻗﺘѧѧѧﺼﺎدﻳﺎ ﻣﻘﺎرﻧѧѧѧﺔ ﺑﺄﻟﺒﻨѧѧѧﺪازول % 01
  .ﻧﺔ ﺑﻤﺮهﻢ ﺗﻴﺮآﺴﻴﻦﻧﻴﻮﻣﺴﺘﻴﺒﺮا ﻳﻌﺘﺒﺮ اآﺜﺮ اﻗﺘﺼﺎدﻳﺔ ﻣﻘﺎر ﻓﺄوﺿﺤﺖ اﻟﺪراﺳﺔ أن اﻟﻌﻼج ﺑﻤﺮهﻢ
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Introduction 
Goats are estimated as 502 millions all over the world, 
approximately 32.4% in Africa. Approximately 6% of the world’s 
goats are found in developed countries and 94% are found in 
developing countries. Goats are highly adaptable to a broad range 
of climatic and geographic conditions and are widely distributed 
than any other mammalian livestock and are managed under every 
imaginable production system including feral, transhumant, 
nomadic, extensive, intensive and total confinement systems. 
Goats are exploited for diverse purposes including meat 
production, cashmere and mohair production, milk and cheese 
production and skin for leather industry. 
During the last decade, worldwide interest in goats has 
increased dramatically and new initiatives for expanding goat 
industries are occurring throughout the world (Smith and Sherman, 
1994). 
Helminthosis in small ruminants is of considerable 
significance in a wide range of agroclimatic zones of Africa and 
affects production through losses due to mortalities and reduced 
weight gain and other losses of production .However, the effects of 
helminth infections on production of the particular livestock species 
 14
depend mostly upon the age of the animal, its breed and the type 
of parasite species. Internal parasites are very common in goats 
and are the cause of a lot of ill health and death (Rollin, 1995). 
Practically all goats, even healthy and productive animals, 
harbor internal parasites. These are primarily various types of 
worms which can live in the stomach, intestine, liver and lungs of 
the goat. Young goats are especially vulnerable to the risk of worm 
infestation. Adult goats first become sick when their general 
condition worsens and consequently parasites there in are able to 
reproduce vigorously. (Mobini and Jaudas, 2006). 
Pneumonia is a non contagious respiratory tract infection 
that can appear in many different forms, perhaps the most 
common being known as shipping fever. Pneumonia is most often 
seen when goats have been kept in crowded and unsanitary 
conditions, especially when the weather turns wet and warm. 
Pneumonia is a very swift killer of goats if not observed and 
treated in time and it is a condition that warrants immediate action 
on the part of the goat owner. (Mobini and Jaudas, 2006). 
Mastitis is an inflammation of the mammary gland which 
together with physical, chemical and microbiological changes of 
the organ is characterized by an increase in the number of somatic 
cells in the milk and by pathological changes in the mammary 
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tissue. The consequences due to reductions in milk yield, changes 
in milk composition, discarded milk and loss of genetic potential 
are serious economic losses for the farmers and the dairy industry. 
Clinical mastitis in which abnormal milk is readily detected, and 
sub-clinical mastitis in which no change in milk is apparent may 
both reduce milk production. (Gianneechini, et,al, 2002). 
 Mastitis was first reported in the Sudan in 1953. (Annual  
report  of the Sudan Veterinary Service, 1953). Since then it has 
been described as being fairly common, (Annual report of the 
Sudan Veterinary Service, 1953 – 1955 and Annual reports of the 
Department of Animal Production, 1956-1957). 
 Mastitis continues to be one of the major disease problems 
facing dairy farmers. (Funk, et.al, 1982). In spite of the control 
efforts (including intensified treatments with antibiotics and 
extensive research) mastitis is still the most important disease 
problem in the dairy industry (Dodd, 1985, Fetrow and Mann, 
1991). For this reason more and exact knowledge from extended 
epidemiological analysis of mastitis and other udder diseases is 
needed for creating better control programmes. 
 Oxytetracycline is a broad spectrum antibiotic available as 
injectable solution with different concentrations (usually 5%, 20%) 
for the treatment of various diseases especially bacterial 
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pneumonia, albendazole the broad spectrum anthelmintic is also 
available as a drench with different concentrations (2.5%, 5%, 
10%) for the treatment of helminthosis, neomastipra and terrexine 
(combination of cefalexin and kanamycin) intramammary infusions 
which are used for the treatment of mastitis are widely used in the 
veterinary field in the Sudan.  
 This study was designed with the following objectives: 
1. To evaluate the efficacy of these different concentrations of 
drugs. 
2. To investigate their economical impact in the treatment of the 
different diseases. 
3. To find out a suitable economical and easy way to be suggested 
for future treatment programme. 
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CHAPTER 1 
Literature Review 
1. Oxytetracycline 
 Oxytetracycline derived from Actinomyces rismosus ( Finaly, 
et.al, 1950). Oxytetracycline is bacteriostatic at therapeutic 
concentrations, but may be bactericidal at higher concentrations 
(Brander, et.al, 1994). 
1.1. Chemical Structure 
 
 
 
 
 
 
 
 
 
1.2. Physical properties 
 Amphoteric oxytetracycline base and its hydrochloride are 
yellow, odourless crystalline powders with a bitter taste. The base 
is only slightly soluble in water, but the hydrochloride is readily 
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soluble. Both are readily soluble, though some turbidity may result 
from the release of oxytetracycline base: buffering with sodium 
glycinate overcomes this. Both base and hydrochloride are readily 
soluble in dilute hydrochloric acid, fairly soluble in methyl and ethyl 
alcohol, but insoluble in chloroform and ether. (Brander, et.al, 
1994). 
 
1.3. Mode of action 
 oxytetracycline is a bacteriostatic antibiotic that inhibits 
protein synthesis in susceptible microorganisms . After diffusion 
through the outer cell membrane, an active carrier mediated 
transports the drug through the inner cytoplasmic membrane. 
Oxytetracycline binds to the 30s ribosomes to prevent access of 
the m RNA – ribosome complex. This prevents the addition of 
amino acids to the growing peptide chain. (Sande and Mandell, 
1980).  
 
1.4. Pharmacokinetics   
 The pharmacokinetics of oxytetracycline were studied in 
goats after the intravenous and intramuscular injection of a 
conventional and a long-acting formulations. The antibiotic was 
distributed according to an open two-compartment model. The 
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apparant volume of distribution (Vd) and the central compartment 
volume (Vc) were 1.443 litres/kg and 0.453 litres/kg respectively, 
and the body clearance was 0.156 litres/kg/hour. The mean half – 
lives ( T ½ ) of the conventional formulation after intravenous and 
intramuscular administration were six hours 28 minutes and 10 
hours  38 minutes, respectively  whereas the long-acting 
formulation had half-lives of six hours 36 seconds and 29 hours 
respectively, after intravenous and intramuscular injections. From 
these results of these single administrations, two intramuscular 
dosage regimens can be proposed that achieve minimum 
concentrations of over 0.5 mg/litre (the minimum inhibitory 
concentration for most susceptible pathogens) with the 
conventional formulation by administering an initial dose of 10 
mg/kg and a maintenance dose of 0.5 mg/kg every 24 hours and 
with the long-acting formulation by administering an initial dose of 
20 mg/kg and a maintenance dose of 14 mg/kg every 48 hours. 
(Escudero, et.al ,1994). 
 The pharmacokinetic behaviour of oxytetracycline (OTC) was 
studied in sheep after intravenous (I/V) and intramuscular (I/M) 
administration of a single dose of 20 mg/kg bodyweight. A 
conventional formulation was injected  by the I/V route and two 
different preparations were administered by the I/M route , a 
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conventional formulation (T-100) and an aqueous  solution of OTC 
with lidocain 1% (OTC-L) with the objective to determine whether 
there are differences between both formulations in the disposition 
kinetics of OTC after the I/M administration to sheep. After the I/V 
administration of the conventional formulation, plasma 
oxytetracycline concentrations were best fitted to an open two-
compartment model. Mean apparent volume of distribution was 
0.77± 0.02 litres/kg and the harmonic mean half-life was 3 hours. 
OTC transfer process between central and peripheral 
compartments was fast and that did not influence the elimination 
process. After I/M administration of both formulations half-lives 
were longer than after I/V administration (mean values of 14.1 and 
58.2 hours for T-100 and OTC-L respectively). In both cases a 
biphasic absorption and a complete bioavailability were found 
OTC-L provided therapeutic plasma concentrations over 0.5 µg/ml 
for a longer period of time than T-100. ( Moreno, et.al, 1998 ). 
 A two-way crossover study was conducted in crossbred male 
calves to determine the bioavailability, pharmacokinetics and 
dosage regimens for a long-acting formulation of oxytetracycline 
(OTC-LA). The half-lives of OTC after I/V and I/M administration 
were 7.4 h and 24 h, respectively. The volume of distribution and 
total body clearance values of the drug were 0.86 ± 0.07 ml/h/kg 
 21
and 76.1± 3.3 ml/h/kg , respectively .The maximum concentration 
of the drug in the serum (4.7 - 7.4 µg/ml ) was achieved 8-10 hours 
after I/M administration The minimum therapeutic serum 
concentration of the drug > or = 0.5 µg/ml was maintained between 
15 minutes and 84 hours after I/M administration. The 
intramuscular bioavailability of the drug was 89.1 ± 4.2 %. The 
dosage regimens to maintain the minimum therapeutic serum 
concentrations of OTC following I/M administration of OTC –LA 
were computed (Kumar and Malik, 1998). 
 Also the serum pharmacokinetic parameters of OTC in goats 
following a single I/M dose of 20 mg/kg of a long-acting 
oxytetracycline formulation were determined with a mean area 
under concentration curve (AUC) = 67.4 µg/h/ml , mean terminal 
half-life 14.4h and apparent clearance 0.033 L/kg/h (Payne, 
et.al,2002) . 
 A study was carried out in cattle to determine the serum 
pharmacokinetics of a standard dose (20 mg/kg bodyweight) of 
oxytetracycline given either as a conventional injectable 
formulation or as a long-acting formulation and the comparison of 
the two regimens showed that the long-acting formulation gave a 
significantly lower peak OTC serum concentration with a significant 
extension of drug serum concentration. The long-acting 
 22
formulation also showed a longer serum half-life and a significantly 
greater area under the curve value calculated from 36 hours 
onwards together with serum OTC concentration which exceeded 
0.5 µg/ml for 86.8 as opposed to 51.5 hours for the conventional 
formulation .(Davy, et.al, 1985). 
 
1.5. Efficacy  
 The in vitro activity of oxytetracycline was determined 
against field isolates of Mycoplasma mycoides mycoides large 
colony (MmmLC) by means of the broth microdilution technique 
and the minimum inhibitory concentration (MIC) of the drug was 
found to be 2.0-4.0 µg/ml and it was shown that resistance to 
MmmLC against oxytetracycline was negligible. 
(Kidanemariam,et.al, 2005). On the other hand the susceptibilities 
of 40 Belgian field isolates of Mycoplasma bovis of 10 antimicrobial 
agents including oxytetracycline were assessed and it was found 
that many strains of M.bovis were resistant to oxytetracycline 
(Thomas, et.al , 2003). 
 The minimum inhibitory concentration of oxytetracycline 
against 24 Sicilian isolates of Mycoplasma agalactiae the 
causative agent of contagious agalactia was determined in vitro 
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giving values of MIC (50) =1.583 and MIC ( 90 ) =2.850 µg/ml. 
(Loria , et.al , 2003).   
 In a field trial performed under commercial feedlot conditions 
in Western Canada to compare the efficacy of a new formulation of 
long-acting oxytetracycline (LA 30) administered intramuscularly at 
a dose rate of 30 mg/kg bodyweight to a standard long-acting 
oxytetracycline formulation administered intramuscularly at a dose 
rate of 20mg/kg bodyweight and florfenicol administered 
intramusculary at a dose rate of 20 mg/kg bodyweight for the 
treatment of undifferentiated fever (UF) in calves that received 
metaphylactic tilmicosin upon arrival at the Feed-lot it was found 
that the overall mortality rate in the LA 30 group of animals was 
significantly lower than in the LA 20 group. However, the overall 
chronicity and overall wastage rates of the LA 30 group were 
significantly higher than in the LA 20 group and there was no 
significant differences in the UF relapse rates between the LA 30 
and the LA 20 groups  (Schunicht, et.al,2002). 
 Topical oxytetracycline proved to be significantly more 
effective than hoof trimming alone and than gluteraldehyde in 
treating digital dermatitis associated with severe heel-horn erosion 
in dairy cattle. (Manske, et.al, 2002). Also the efficacy of topical 
oxytetracycline solution and a commercial formulation of soluble 
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copper peroxide compound and a cationic agent was compared in 
treating dairy cows with papillomatous digital dermatitis and it was 
found that on the basis of pain and lesion scores oxytetracycline 
solution and the commercial formulation appeared equally effective 
for treatment of papillomatous digital dermatitis. (Hernandez, et.al , 
1999). 
 The susceptability of various strains of Mycoplasm bovis, 
Mycoplasma dispar and Ureaplasma diversum which are the 
prevalent causes of pneumonia in calves to 16 antimicrobial 
agents including tetracyclines in vitro was determined and the 
MICs of the antimicrobial agents were also determined and it was 
found that most strains of U. diversum were intermediately 
susceptible to oxytetracycline, but fully susceptible to 
chlortetracycline, most strains of M bovis and M. dispar ,however, 
were resistant to both agents . The type strains of M bovis and M. 
dispar were more susceptible the various antimicrobial agents 
including tetracyclines than the field strains, this finding might 
indicate M. bovis  and M. dispar strains are becoming  resistant to 
these agents . (Laak, et.al, 1993).  
 The clinical efficacy of oxytetracycline LA administered 
intramuscularly for the treatment of keratoconjuctivitis infectiosa 
ovis was tested and it was found that oxytetracycline LA had a 
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clearly positive effect on the clinical course of “pink eye” and 
advised to be dosed at rate of 20-30 mg/kg and if necessary to be 
repeated on days 5 and 10 after the intramuscular injection (König 
, 1983). 
 A Study was conducted in calves naturally infected with 
infectious bovine keratoconjuctivitis (IBK) in an outbreak, they 
received treatment with oxytetracycline in a combined regimen 
parenteral and oral administration in comparison with 
subconjunctival administration of procain penicillin G and it was 
found that calves treated with oxytetracycline had a lower 
prevalence of IBK than did calves treated with procain penicillin G 
and they required fewer additional treatments, also mean time for 
healing of corneal ulcers was significantly less and developed 
fewer corneal ulcers and recurrent ulcers in calves treated with 
oxytetracycline than did others treated with procain penicillin G. 
This clinically implicated that combined parenteral and oral 
administration of oxytetracycline appears to be an effective method 
of reducing severity of a herd outbreak of IBK and may be superior 
to treatment of affected animals with procain penicillin G.  
(Eastman, et.al, 1998).  
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2. Albendazole 
 Albendazole is a member is of benzimidazoles group of 
anthelmintics which appeared in the early 1960s and since then 
have been subjected to continuous structural modifications to 
improve their safety and spectrum of activity. (Brander, et.al,1994). 
 
2.1. Chemical structure 
 Albendazole is methyl (5- propylthio- 1H- bezimidazole- 2- yl) 
carbamate .  
  
 
 
 
2.2. Physical properties 
 Albendazole is a white to off-white powder insoluble in water, 
soluble in demethylsulfoxide, strong acids and strong bases, 
slightly soluble in methanol, chloroform, ethylacetate and 
acetonitrile. 
 
2.3. Spectrum of activity 
 Albendazole is a broad spectrum anthelmintic active against 
all important nematodes and their larvae, including hypobiotic or 
 27
inhibited forms. It is also effective against tape worms and adult 
flukes. (Brander, et.al, 1994). 
 
2.4. Mode of action 
 It has been shown to disrupt energy metabolism in worms, 
either by inhibiting the enzyme fumarate reductase or by 
polymerizing tubulin in the microtubules of cells  (Brander, et.al, 
1994). 
 
2.5. Pharmacokinetics 
 Albendazole was given to eight male New Zealand white 
rabbits divided into two groups as a single dose at rate of 150 
mg/kg suspended in 0.5 % carboxy methyl cellulose (CMC) either 
as intraperitoneal (I/P) injection or by oral administration and the 
concentration of albendazole and its metabolites in plasma were 
determined using a high performance liquid chromatography 
method and it was found that the parent drug was detected in 
plasma after oral and intraperitoneal administration. The C(max) of 
albendazole sulphoxide  resulted in a much higher plasma 
concentration in the oral group (41.86 µg/ml) than in the I/P group 
(16.84 µg/ml). The area under the concentration over time curve of 
albendazole sulphoxide in the oral group (1010 .43µg/ml/h) was 
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also significantly higher than that of the I/P group (528.33 
µg/ml/ml/h). (Cai, et.al, 2007).  
 Several activities of liver biotransformation enzymes and in 
vitro metabolism of albendazole were tested and compared in non-
infected moulfons (ovis musimon) and in moulfons infected with 
lancet fluke (Dicrocoelium dendriticum), from the eight enzyme 
activities that were assayed , only two activities significantly differ 
in the case of Dicrocoelium- infected versus non-infected animals, 
in infected moulfons a significant increase (53%) of 
thiobenzamide-s-oxidase (TBSO) activity, corresponding mainly to 
the activity of flavine monooxygenase (FMO), and significant 
decrease (60%)  of glutathione-s-transferase (GST) activity was 
observed. In addition, dicrocoeliosis caused enhancement of 
albendazole hepatic biotransformation. The velocity of the 
formation of (+) albendazole sulphoxide and albendazole sulphone 
was significantly increased and from this point of view the use of 
albendazole in the therapy of moulfon dicrocoeliosis in young 
animals can be recommended. (Skalova, et.al, 2007). 
 
2.6. Efficacy  
 Efficacy of albendazole was tested in sheep artificially 
infected with Haemonchus contortus and they received treatment 
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with albendazole at a dose rate of 3.8 mg/kg, efficacy was tested 
by faecal egg count reduction (FECR) and total worm count 
reduction (TWCR), on day 2 post treatment, significant FECR (p< 
0.001) was detected and the animals showed significant increase 
in PCV (p< 0.05). (Eguale, et.al, 2007). 
  A clinical longitudinal field trial was conducted on a dairy 
sheep farm in southern Italy to assess the effectiveness of a novel 
anthelmintic treatment strategic scheme against Fasciola hepatica. 
The scheme utilizes a dual anthelmintic treatment (DAT), i.e, the 
use of either one of different anthelmintics on the flock, 
albendazole sulphoxide at 1-month intervals and rafoxanide at 2-
month intervals administered to lactating and non-lactating 
animals, respectively. The DAT strategic scheme lasted 3 years 
and it was found that the DAT scheme reduced  the prevalence of  
Fasciola hepatica  infection by 94.4%  (from an average 
prevalence of 71% during the pre-DAT period to an average 
prevalence of 4.0% during 3 years) , and number of eggs per gram 
of faeces (EPG) from 29.3-1.3, and it was concluded that the DAT 
strategic scheme reported in this study successfully reduced in 
both the prevalence  and EPGs of F. heptica to a level at which 
there were no longer any clinical symptoms of the disease  and 
this scheme did not  influence the  albendazole sulphoxide efficacy 
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against gastrointestinal nematodes and might be used for the 
treatment of fasciolosis in dairy sheep farms. (Cringoli, et.al, 2006). 
 A controlled trial was conducted in Turkey during the spring 
to evaluate the current efficacy of albendazole given orally at a 
dose rate of 12 mg/kg bodyweight, rafoxanide orally at 10 mg/kg, 
triclabendazole orally at 12 mg/kg and clorsulon subcutaneously at 
2mg/kg against Fasciola hepatica in naturally infected cattle. The 
drug efficacy was assessed as a percentage of the egg or fluke 
reduction and body weight gain in relation to the untreated group 
of animals left as a control , the results in the study showed a 
mean reduction of eggs counts by 66.7%, 68.2%,78% and 84.2%  
respectively.( Elitok, et.al,2006 ).  
 The efficacy of albendazole given at 5,10 or 20 mg/kg /day 
alone and thalidomide at 25,50 or 100 mg/kg /day alone or a 
combination of albendazole of  10 mg/kg/day and  thalidomide 50 
mg/kg/day for 7 consecutive days given to BALBIC mice 
experimentally infected with Angiostrongylus cantonensis on day 
5,10 and 15 days post- inoculation respectively was assessed 
using worm recovery, histopathological score of meningitis, 
eosinophil counts, level of pro-inflammatory cytokines, activity of 
enzymes such as tissue type plasminogen activator, urokinase 
type plasminogen activator and matrix metalo proteinase -9- and 
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CSF/ serum albumin ratio as indicators, the results showed  that 
albendazole / thalidomide co-therapy significantly decreased these 
factors when treatment was initiated on days 5 or 10 post 
inoculation and it was concluded that the timing of  medication use 
is important and is closely related to the anthelmintic efficacy of a 
drug, for a given dosage earlier medication use is more effective . 
(Chen and Lai, 2007).  
  
3. Pneumonia 
3.1. Definition 
 Pneumonia is the inflammation of the pulmonary 
parenchyma usually accompanied by inflammation of the 
bronchioles and often by pleurisy. It is manifested clinically by an 
increase in respiratory rate, cough, abnormal breath sounds on 
auscultation and in most bacterial pneumonias by evidence of 
toxaemia. (Blood and Henderson, 1989). 
 
4.2. Etiology of pneumonia 
 In addition to the infectious agents which cause the 
pneumonia there are predisposing factors which contribute to the 
susceptibility of the animal. Pneumonia can be caused by viruses, 
bacteria or a combination of both, fungi, metazoan parasites and 
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physical and chemical agents. Most of the pneumonias in animals 
are bronchogenic in origin, but some originate by the 
haematogenous route. (Blood and Henderson, 1989). 
 
3.3. Pneumonia in goats  
 Pleuropneumonia caused by Mycoplasma strain F 38 or 
Mycoplasma Capri is a devastating disease. Chronic interstitial 
pneumonia with cor pulmonale as a common sequel may be 
caused by a number of Mycoplasma species, but Mycoplasma 
mycoides var mycoides appears to be the most commonly 
recorded. Other types include retrovirus, toxoplasmosis rare 
sporadic cases, systemic mycosis, aspiration  pneumonia, 
sporadic secondary pneumonia caused by streptococcus species, 
Corynebacterium sp. and Dermatophilus sp. (Blood and 
Henderson, 1989). 
 
3.4. Treatment of pneumonia  
 This disease is the major cause of loss in growing stock and 
use of antibiotics is still the main therapeutic approach to the 
problem. The causes, however, are known to include viruses 
which would not be affected by the antibiotics presently available, 
and mycoplasmas which are affected by only some of antibiotics 
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e.g tylosin, spectinomycin and tiamulin. Thus choice of antibiotic 
should include consideration of the etiology, but also the ability of 
the antibiotics to penetrate into the tissue of the lung, which is vital 
if the drug is to reach its site of action. The relative ability of 
different drugs in this respect is not well defined, partly because of 
the difficulty of marking measurements of concentrations in the 
lungs, but certain generalizations can be made. Firstly tissue 
penetration is not particularly good with the penicillins, although 
they have a long record of success in treating lung infections. 
Tetracyclines, however, are said to be concentrated in the lung. 
The macrolides (particularly spectinomycin) are also concentrated 
in tissue fluids, so making them very appropriate. (Brander, et.al, 
1994). 
 The choice of antibacterial agent will depend on the tentative 
diagnosis, the experience with the drug in previous cases and the 
results of drug sensitivity test. The common bacterial pneumonias 
of all species will usually recover quickly (24 hours) if treated with 
an adequate dose of the drug of choice early in the course of the 
disease. Animals with severe pneumonia will require daily 
treatment for several days until recovery occurs. Antibacterial 
agents in a long-acting base may be used to provide therapy over 
a 4-6 day period instead of the daily administration of the shorter-
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acting preparations. However, the blood levels from the long-acting 
preparations are not as high as the short-acting preparations and 
may not be as effective in severely infected animals. There is no 
specific treatment for the viral pneumonias and while many of the 
Mycoplasma spp. are sensitive to antibiotics in vitro, the 
pneumonias caused by them do not respond favorably to 
treatment. This may be due to the intracellular location of the 
Mycoplasma making them inaccessible to the drugs. Because viral 
and mycoplasmal pneumonias are commonly complicated by 
secondary bacterial infections, it is common practice to treat acute 
viral mycoplasmal pneumonias with antibacterials until recovery is 
apparent. (Blood and Henderson,1989). 
 
4. Internal parasites in ruminants 
 Internal parasites in ruminants constitute a problem that 
returns periodically in almost all livestock herds. Helminthosis is 
considered to be a major cause of mortality and sub-optimal 
productivity in goats and sheep in traditional farming systems. 
Helminths cause direct losses due to deaths and indirect losses 
due to reduced productivity through reduced feed intake and live 
weight gains and decreased quality of skins, wool or mohair 
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.Furthermore, they render animals more susceptible to other 
infections.(Lughano and Dominic, 1996) 
 
4.1. Etiology 
 Helminthiosis is a widespread infection of small ruminants. 
Nematodes, trematodes and cestodes are the three major classes 
of parasitic helminthes of economic and zoonotic importance 
affecting goats and sheep. (Lughano and Dominic, 1996). 
 
4.2. Common helminths of ruminants 
4.2.1 Round worms 
 Haemonchus spp.- large blood-sucking worms occupying the 
abomasums and highly pathogenic to lambs. 
Ostertagia spp.- common abomasal worms of cattle and 
sheep are the principal contributors to summer worm disease 
(Type I) and winter disease (Type II) in cattle. 
 Trichostrongylus spp.- tiny, but prolific small intestinal 
worms, often causing disease in growing lambs. T. axei can be 
found in the abomasums of sheep, goats and cattle. 
 Cooperia spp. -occur in the small intestine of sheep 
and cattle and sometimes cause clinical bovine disease. 
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 Nematodirus spp.-of no significance in cattle. One 
species (N.battus) causes fatal outbreaks of disease in young 
lambs. 
 Bunostomum spp.- a blood- sucking hook worm, rarely 
of economic significance. Infection is acquired by larvae 
penetrating the skin and migrating to the gut via the blood stream. 
 Dictyocaulus spp.- found in the lungs of ruminants , 
which the larvae reach via the lymphatic system. It is responsible 
for the fatal epidemic of " Husk " in young cattle. 
 Chabertia spp.- large worms inhabiting the 
colon.Common , but not usually pathogenic. 
 Oesophagostomum spp.- large worms of the colon and 
caecum. Larvae may provoke a host reaction that produces 
nodules along the gut. 
 Strongyloides spp.- economically unimportant worms of 
small intestine. Only parthenogenetic females are parasitic , with 
the sexual cycle free-living. Infection is by skin penetration or to 
the neonates by the mother’s milk. 
 Trichuris spp.- large whip-like worms inhabiting the 
caecum. 
 Capillaria spp.- thin filamentous worms of the small 
intestine. 
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4.2.2. Flukes 
 Fasciola hepatica – the only trematode of veterinary 
importance in temperate zones capable of infecting the liver of any 
mammal, but is most prevalent in sheep and cattle . Acute disease 
caused by the invasion of young flukes is often fatal to sheep. In 
tropical climates it is often replaced by the larger species F. 
gigantica. 
 Dicrocoelium dendriticum – a much smaller 
"lanceolate" liver fluke.  
 Amphistomes- large cylindrical flukes occupying the 
reticulum and rumen of beasts mainly in tropical and subtropical 
regions. Heavy infestations may be pathogenic. 
 
4.2.3. Tapeworms 
 Moniezia spp.- large worms of small intestine. Heavy 
infections may be responsible for unthriftness in lambs. 
 Larval forms- cysts of several tapeworms may cause 
disease ( e.g  Coenurus cerebralis in the brain of sheep ), carcass 
condemination (liver hydatids of Echinococcus) or infection in man 
( Cysticercus bovis in muscles of cattle). (Brander, et.al, 1994). 
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4.3. Effect of parasites on their hosts 
 There are many species of parasites which are relatively 
harmless, but there are also many forms which produce 
pathological changes which may lead to severe ill health or death 
of the host. The parasite may compete with the host for food, the 
parasite indirectly may be the cause of decreased food utilization 
by the host, it may cause reduced appettite with a concomitant 
reduction of food intake. Changes in the absorptive surface of the 
intestine may result in marked alterations in the influx and efflux of 
water and sodium and chloride ions into the bowel in 
morphological and biochemical changes in epithelial cells and their 
microvilli. The removal of host tissues and fluids by parasites is 
best illustrated by the blood-sucking activities of certain 
nematodes, in some cases death of the host is directly attributed to 
excessive loss of blood. One of the most common effects of 
parasitism is destruction of the host tissues, this may be a 
mechanical action when the parasites and their larval stages 
migrate through or multiply in tissues or organs, or when various 
organs of attachment are inserted into the tissues as anchors. 
Destruction may be by pressure as a parasite grows larger or by 
blockage of ducts such as blood vessels to produce infarction, of 
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lymph vessels to produce oedema and elephantiasis or of the 
intestinal canal to produce necrosis and rupture.(Soulsby, 1986). 
 
5. Mastitis 
5.1. Definition 
 The term mastitis refers to the inflammation of the mammary 
gland regardless of the cause. It is characterized by physical, 
chemical and usually bacteriological changes in the glandular 
tissue. The most important changes in the milk are discoloration, 
presence of clots and a large number of leukocytes. Although 
there is swelling, heat, pain and induration in the mammary gland 
in many cases, a large proportion of mastitic glands are not readily 
detectable by manual palpation or by visual examination of milk 
using a strip cup. ( Blood, et.al, 1983). 
 
5.2. Etiology of mastitis 
 Although mastitis is caused by both non-infectious (traumatic 
or toxic) and infectious agents, microorganisms are the most 
important etiological agents including a wide variety of bacteria 
aerobic, facultative anaerobic, micro aerophilic and anaerobic, 
mycoplasmas, yeasts, fungi, moulds, algae, viruses and 
rickettsias. (Allen,1985). 
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 Organisms causing mastitis can be divided into contagious 
organisms that colonize the mammary gland and can be spread by 
milking machines and milkers and enviromental pathogens that do 
not normally infect the mammary glands, but can do so when the 
cow’s enviroment , the teats and the udder or the milking machine 
are contaminated with these organisms and they can gain access 
to the teat cistern. (William,1995). 
 Sources indicate that 80% - 99% of mastitis infections are 
caused by four types of organisms including Staphylococci, 
Streptococcus agalactiae, other streptococcal species and 
coliforms. (Dodd,1971). 
 
5.3. Classification of mastitis  
 Mastitis may be classified as clinical or subclinical depending 
on the degree of inflammation. (Philpot,1967). Clinical mastitis is 
defined by the diagnosis of abnormal changes in the body, udder 
and milk with concurrent decrease of at least 25% in daily milk 
production.(Shpigel, et.al, 1994). Clinical mastitis may further be 
classified according to the severity of inflammatory response as 
mild, acute, peracute or chronic. Infection of each mammary gland 
occurs via the teat canal, the infection originating from two main 
sources, the contaminated udder and the environment. Bacteria 
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which are normal inhabitants of the environment cause mastitis 
much less frequently but, when they do, the disease is much more 
resistant to hygienic measures. Sub clinical mastitis on the other 
hand, can not be detected by visual observation, though it can be 
identified by tests that detect infecting microorganisms or the 
products of inflammation such as somatic cells. Subclinical mastitis 
is 15-40 times more prevalent than the clinical form, it is of long 
duration, reduce milk production and adversely affects milk quality. 
(Philpot, 1967). 
 
5.4. Mastitis in goats 
 Goats are much less affected by mastitis than cattle and 
details of infections encountered are inconsistent, coliform 
organisms, for example, are listed as not occurring. (Hunter, 
1984), or being most common (Lewester,1984). Staphylococcus 
aureus is usually considered to be the most important pathogen. 
(Manser1986). Other infections are Mycoplasma agalactiae, 
Mycopalsma mycoides var. mycoides, Sterptococcus agalactiae, 
Streptococcus dyagalactiae, Streptococcus pyogenes and Yersinia 
pseudotuberculosis. (Cappucci, et.al,1978). 
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5.5. Treatment of mastitis 
 Treatment of mastitis can be highly effective in removing 
infection from the quarter and returning the milk to normal 
composition. However, the yield of milk although it can be 
improved by the removal of congestion in the gland and the 
inflammatory debris from the duct system, is unlikely to be 
returned to normal, at least until next lactation.  
 The degree of response obtained depends particularly on the 
type of the causative agent, the speed with which treatment is 
commenced and other factors. The first decision is whether to treat 
a particular case systemically by parenteral injection or locally by 
intramammary infusion. Having decided that there is a still a 
serious problem of selecting the best antibacterial agent for the 
particular pathogen involved. In the past the bulk of these 
decisions have been based on in vitro tests and although some of 
in vivo data is now available the choice of drugs is still largely 
dependent on findings about the actual effectiveness of each drug 
in particular circumstances. (Ziv,1980). 
 The intamammary route is the most satisfactory both where 
the disease is acute or where it is subclinical where there is no 
clinical signs even in the udder but, limited to the udder, in the 
latter case routine treatment with an antibiotic at drying- off  is the 
 43
most useful approach. The choice of an intramammary antibiotic 
for lactation (acute) therapy should take into account the following, 
a low MIC against the main pathogens in mastitis. These are 
staphylococci, streptococci and less commonly E.coli, minimal 
irritancy to the udder tissue, low degree of binding to milk and 
udder tissue protein, chemically a weak base or highly unionized in 
milk this will assist in penetration through udder tissue as will lipid 
solubility and a short milk- withholding period so as to allow rapid 
return of the to the milking herd. (Ziv, 1975). 
 
5.6. Choice of intramammary infusion 
 Because of the preponderance of Staphylococcus aureus 
infection the recommended antibiotics are benzathine cloxacillin , 
neomycin and novobiocin , but more important is the need for the 
antibiotic to be in a long- acting base because most dry-period new 
infections arise in the first 3 weeks of the drying off period, and a 
slow release base with a suitable antibiotic will maintain a 
minimum effective concentration for 25 day. Besides the base in 
which the drug is suspended it is desirable to use an antibiotic 
which has an affinity of binding to mammary tissue and secretions, 
and is therefore likely to remain in the udder rather than be 
absorbed into the bloodstream. The antibiotics most likely to be 
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satisfactory in this respect are neomycin, dihydrostreptomycin, 
spiramycin, polymixin B, cloxacillin, novobiocin and phenoxymethyl 
penicillin. (Ziv, et.al,1976).    
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CHAPTER 2 
Materials and Methods 
1. Experiment 1 
1.1. Animals 
Nine Nubian goats were purchased from Abu Zeid animal 
market, Khartoum state. They were divided into three groups 
and fed with alpha alpha (Barseem) and given water ad 
libitum. 
1.2. Drugs 
 Drugs used in this experiment were 
1. Oxytetracycline 5% injectable solution (Limoxin-50, 
Interchemie, Holland). 
2. Oxytetracycline 20% injectable solution (Limoxin-200 
LA, Interchemie, Holland). 
1.3. Blood sampling 
 Whole blood was taken by venepuncture from the jugular 
vein using heparinized vaccutainer tubes. 
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1.4. Respiratory rate taking 
 Respiratory rate from each animal was counted visually by 
observing the movement of the flank region and manually using 
stethoscope at 24 hour intervals. 
 
1.5. Temperature taking 
 Temperature was taken from each animal by means of 
thermometer from the anus at 24 hour intervals. 
 
1.6. Differential count of white blood cells 
 A blood film was prepared from fresh blood containing EDTA 
as an anticoagulant and was stained with Leishman’s stain and 
examined under oil immersion objective.100 leucocyte cells were 
counted and differentiated into neutrophils, eosinophils, basophils, 
monocytes and lymphocytes as described by Kelly (1984). 
 
1.7. Haemoglobin concentration (Hb) 
 Hb concentration was determined by cyanomethaemoglobin 
method as described by Van Kampen Zijlstra (1961). 
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Principle 
 Ferrous ions of Hb are oxidized to the ferric  state by 
potassium ferricyanide to form methaemoglobin , which reacts with 
cyanide to form cyanomethaemoglobin  that can be measured 
calorimetrically. 
Reagent 
Cyanide reagent (Drabkin’s solution) 
 A mix of 0.2g potassium cyanide, 0.05g ferricyanide and 
0.14g of potassium hydrogen diorthophosphate was dissolved in 1 
litre of distilled water. 
Standard Hb solution 
 One ml of human Hb standard ( Biosystem- Spain), with 
concentration of 11.5g/dl was used as standard. 
Procedure 
 Clean dry test tubes were prepared for sample and standard 
, 4 ml cyanide reagent was added to each tube. Then 0.2 ml of 
blood sample and Hb standard solution were added to the samples 
and standard tubes, respectively. They were allowed to stand for 
15 minutes, then the optical density (O.D) was read at 540 nm in 
spectrophotometer  using cyanide reagent as blank. 
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Calculation 
 Hb concentration (g/dl)═ O.D sample X 11.5 
 
1.8. Samples for histopathology 
 Portions of lungs from each dead animal were fixed in 10% 
neutral formalin. Selected sections were embedded in paraffin, 
sectioned at 6µ and stained with haemotoxylin and eosin. 
 
1.9. Nasal swabs collection 
 The nostrils were prepared by washing and drying and then 
wiped clean with a swab of cotton wool moistened with 70% 
alcohol and allowed to dry. Then sterile swabs were introduced 
inside the nasal cavity and the swabs samples were taken for 
culture. 
 
1.10. Preparation of media 
 Media required for culture of samples were prepared as 
described by Barrow and Feltham (1993). 
 
 
 
O.D standard 
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1.10.1. Nutrient agar medium 
 Twenty eight grams of powder Difico nutrient agar were 
dissolved in one litre of distilled water in a flask, sterilized by 
autoclaving at 121cْ for 15 minutes. 20 ml of the medium was 
poured onto a Petri dish (9cm) and let to solidify. 
 
1.10.2. Blood agar 
Defibrinated blood            50 ml 
Nutrient agar                     950  
  The nutrient agar was melt, cooled to 50 c and the blood was 
added aseptically mixed and distributed in plates. 
 
1.10.3. McConkey agar 
Peptone                                                       20 g 
Nacl                                                             5g 
Sodium taurocholate                                   5g 
Lactose                                                        20g 
Agar                                                             20g 
Neutral red 1% aqueous solution                10 ml 
Water                                                          1000 ml 
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 The peptone, Nacl and bile salt were dissolved in the water 
by heating. The PH was adjusted to 8.0 by boiling for 20 minutes, 
then cooled and filtered. The agar was dissolved and added and 
the PH adjusted to 7.4. Lactose and indicator solution were added, 
mixed and sterilized at 115cْ for 20 minutes.  
 
2. Experiment 2 
 
2.1. Animals 
 Nine naturally infected goats with Tricostrongylidae spp. 
were used in this experiment divided into three equal groups. 
 
2.2. Drugs 
 Drugs used in this experiment were  
1. Albendazole 2.5% (Albenko, Shenyang). 
2. Albendazole 5% (Tramazole,Ireland). 
3. Albendazole 10% ( Albenko, Shenyang). 
 
2.3. Faecal sampling 
 Faecal samples were collected from the rectum into 
petridishes. 
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2.4. Blood sampling 
 Blood samples were collected as mentioned above in 
experiment I. 
 
2.5. Faecal egg count 
 Number of eggs per gram of faeces were determined using 
McMaster method as described by Kelly (1984). 
 
McMaster method 
 Two gram of faeces were weighed out and placed in a 120 
ml  wide-mouthed glass stoppered bottle containing  about four 
dozen small glass balls and marked at 60 ml level. Saturated 
sodium chloride solution was added to the 60 ml mark, the 
glass stopper inserted and the bottle and contents shaken until 
the faeces were broken up. The mixture was then poured 
through a fine wire mesh screen with an aperture of 0.15 mm 
into a small beaker and the debris discarded. The faecal filtrate 
was agitated and with a Pasteur pipette sufficient amount was 
withdrawn to fill one chamber of the special counting slide .The 
residue in the pipette was returned to the bulk filtrate which is 
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reagitated and a further quantity withdrawn to fill the second 
chamber on the slide. The charged slide was then placed on the 
stage of the microscope, and after focusing a corner of the 
etched lines with the 1.6 cm objective, all eggs in the two 
chambers were counted by moving up and down the columns of 
lines. The total number of ova multiplied by 100 gives the 
number of eggs per gram of faeces (epg). 
 
 
2.6. Haemoglobin concentration (Hb) 
 Hb concentration was determined by cyanomethaemoglobin 
method as described by Van Kampen Zijlstra (1961). 
 
3. Experiment 3 
3.1. Animals 
Six goats naturally infected with mastitis were used in this 
experiment. 
 
3.2. Drugs 
1.Two intramammary infusions were used: 
 53
I. Neomastipra –JR5 (Hipra laboratories,S.A.,Spain) composed of 
benzyl penicillin 100000 i.u, dihydrostreptomycin sulphate 62.5 
mg, neomycin sulphate 36 mg, polymyxin B sulphate 50000 i.u, 
sulphadimidine sodium 250 mg, sulphathiazole 250 mg and 
hydrocortisone 20 mg.   
II. Terexine (Univet, Ireland) composed of cefalexin 200 mg and 
kanamycin monosulfate monosulfate 100000 i.u.  
 
3.3. Milk sample collection 
 The udder was prepared by washing and drying, the foremilk 
from the affected udder was discarded and then the tip of the teat 
was wiped clean with a swab of cotton wool moistened with 70% 
alcohol and allowed to dry. Then milk sample was then drawn into 
a sterile wide-mouth screw capped bottle which was held in a 
horizontal position. 
 
3.4. Culturing of milk samples 
 All samples were streaked onto blood agar and incubated 
aerobically at 37 cْ for 18-24 hours. 
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Staining technique 
 Smears were made from the cultured colonies and stained 
with Gram’s stain described by Barrow and Feltham (1993). 
 
4. Statistical analysis 
 Statistical analysis of data was carried out by applying  
analysis of variance (ANOVA)  using Duncan’s multiple range test 
described by Snedecor and Cochran (1989). 
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CHAPTER 3 
Results 
1. Experiment 1 
1.1. Body temperature  
 There was no significant difference in body temperature 
(p>0.05) in weeks 2 and 3 compared with week 1 in groups 1, 2 
and 3 which received treatment with oxytetracycline 5%, 
oxytetracycline 20% and non-treated control, respectively as 
shown in table 1 and figure 1. 
 
1.2. Respiratory rate 
 There was no significant difference (p>0.05) in respiratory 
rate in week 2 compared with weeks 1and 3, but there was 
significant decrease (p<0.05) in respiratory rate in week 3 
compared with week 1 and 2 in group 1 which received treatment 
with oxytetracycline 5%, and there was no significant difference 
(p>0.05) in respiratory rate between weeks 1, 2 and 3 in group 2 
which received treatment with oxytetracycline 20%, and there was 
significant increase (p<0.05) increase in respiratory rate in weeks 2 
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and 3 compared with week 1 in group 3 the non-treated control as 
shown in table 2 and figure 2. 
 
1.3. Haemoglobin concentration 
 There was no significant increase in haemoglobin 
concentration (p>0.05) in weeks 2 and 3 compared with week 1 in 
group 1 which received treatment with oxytetracycline 5%, while 
there was significant increase in hemoglobin concentration 
(p<0.05) in weeks 2 and 3 compared with week 1 in group 2 which 
received treatment with oxytetracycline 20%, and no significant 
difference in haemoglobin concentration in weeks 2 and 3 
compared with week 1 in group 3 the non-treated control as shown 
in table 3 and figure 3. 
 
1.4. Differential count of the white blood cells 
1.4.1. Neutrophils 
 There was significant increase in neutrophils count 
(p<0.05%) in weeks 2 and 3 compared with week 1 in group 1 
which received treatment with oxytetracycline 5%, while there was 
significant decrease in neutrophils count (p>0.05%) in weeks 2 
and 3 compared with week 1 in group 2 which received treatment 
 57
with oxytetracycline20%, and no significant difference(p>0.05%)  
in weeks2 and 3 compared with week 1 in group 1 the non-treated 
control as shown in table 4 and figure 4. 
 
1.4.2. Lymphocytes 
 There was significant decrease in lymphocytes count 
(p<0.05) in weeks 2 and 3 compared with week 1 in group 1 which 
received treatment with oxytetracycline 5%, while there was 
significant increase in lymphocytes count (p>0.05%) in weeks 2 
and 3 compared with week 1 in group 2 which received treatment 
with oxytetracycline 20%, and no significant difference in 
lymphocytes count (p>0.05%) in weeks2 and 3 compared with 
week 1 in group 1 the non-treated control as shown in table 5 and 
figure 5. 
 
1.4.3. Monocytes 
 There was no significant difference in monocytes count 
(p>0.05%) in weeks 2 and 3 compared with week 1 in groups 1,2 
and 3 which received treatment with oxytetracycline 
5%,oxytetracycline 20% and non-treated control, respectively as 
shown in table 6 and figure 6. 
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1.4.4. Eosinophils 
 There was no significant difference in eosinophils count 
(p>0.05%) in weeks1, 2 and 3 in groups 1,2 and 3 which received 
treatment with oxytetracycline 5%, oxytetracycline 20% and non-
treated control, respectively as shown in table 7 and figure 7. 
 
1.4.5. Basophils 
 There was significant difference in basophils count (p<0.05) 
in weeks 2 and 3 compared with week 1 in groups 1 and 2 which 
received treatment with oxytetracycline 5%and oxytetracycline 
20%, while there was no significant difference in basophils count 
(p>0.05) in weeks 1, 2 and 3 in group 3 the non-treated control as 
shown in table 8 and figure 8. 
 
1.5. Necropsy findings 
 Lungs of animals in group 1 and 2 which received 
treatment with oxytetracycline 5% and oxytetracycline 20%, 
repectively showed normal appearance while those of group 3 the 
untreated control showed pneumonic lungs with areas of 
hepatization as shown in Figures 12, 13 and 14.  
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1.6. Histopathological findings 
 Sections from lungs taken from animals of group 1 treated 
with oxtetracycline 5% revealed large areas of emphysema, 
thickening of  interstitial tissues especially around the bronchioles, 
some alveoli show cuboid form of epithelium and there was 
infiltration with mononuclear cells in the interstitial tissue . Lungs of 
animals in group 2 treated with oxtetracycline 20% revealed 
smaller areas of emphysema, interstitial thickening and also some 
alveoli show cuboid form of epithelium. Lungs of animals in group 
3 the untreated revealed loss of alveoli and most of them 
collapsed, severe cellular reaction most of them mononuclear 
cells, hyperplasia of bronchial epithelium, presence of cellular 
exudates composed of round cells and some neutrophils and 
peribronchial lymphoid hyperplasia as shown in figures 12,13 and 
14.  
        
1.7. Microbiological findings 
 Nasal swabs were taken before treating the animals for 
culture and identification of the causative agent and the following 
microorganisms were isolated. E. coli, Klebsiella pneumoniae, 
Streptococcus pneumoniae, Providencia alcalifacins, 
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Actinobacillus equuili and Neisseria mucosa. Necropsy samples 
from the lungs after slaughter of the animals after three weeks post 
treatment were taken for culture and the results showed that there 
was no growth from samples taken from group 1 and 2 which 
received treatment with oxytetracycline 5% and oxytetracycline 
20%, respectively.  
 
2. Experiment 2 
2.1. Body weight gain 
There was no significant increase in body weight gain 
(p>0.05) in weeks 2 and 3 and 4 compared with week 1 in groups 
1,2 and 3 which received treatment with albendazole 
2.5%,albendazole 5% and albendazole 10%, respectively as 
shown in table 9 and figure 9. 
 
2.2. Haemoglobin concentration   
 There was no significant increase in haemoglobin 
concentration (p>0.05) in weeks 2 and 3 and 4 compared with 
week 1 in groups 1,2 and 3 which received treatment with 
albendazole 2.5%,albendazole 5% and albendazole 10%, 
respectively as shown in table 10 and figure 10. 
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2.3. Egg count  
 There was significant decrease in the number of eggs per 
gram of faeces (p<0.05) in weeks 2, 3 and 4 compared with week 
1 in groups 1,2 and 3 which received treatment with albendazole 
2.5%,albendazole 5% and albendazole 10%, respectively as 
shown in table 11 and figure 11. 
 
3. Experiment 3 
1.3. Microbiological findings 
 Milk samples were taken from infected udders before 
treatment for culture and identification of the causative agent and 
was identified as Actinomyces pyogenes.  
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Weeks Groups 
1 2 3 
 Group 1 38.63±0.13a 38.44±0.15a 38.79±0.21a 
 Group 2 39.03±0.19a 38.98±0.20a 38.51±0.17a 
 Group 3 38.94±0.20a 38.93±0.17a 39.23±0.26a 
Table 1. Body temperature 
Group 1 =  treated with OTC 5% 
Group 2 =  treated with OTC 20% 
Group 3 =  non-treated control 
Means in the same row with the same letter are not significantly different (p>0.05) 
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Weeks Groups 
 
 
1 2 3 
Group 1 18.11±0.76a 15.83±1.08ab 14.72±0.58b 
Group 2 18.39±0.47a 18.72±0.49a 18.06±0.73a 
Group 3 14.33±0.63b 17.94±0.96a 17.06±0.47a 
Table 2.  Respiratory rate  
Group 1 =  treated with OTC 5% 
Group 2 =  treated with OTC 20% 
Group 3 =  non-treated control      
Means in the same row with the same letter are not significantly different (p>0.05) 
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Weeks Groups 
1 2 3 
Group 1 8.53±1.05a 10.20±1.10a 10.73±0.32a 
Group 2 8.27±0.24b 11.07±0.79a 10.17±0.32a 
Group 3 8.20±0.31a 8.90±0.90a 8.57±1.11a 
Table 3.  Haemoglobin concentration 
Group 1 =  treated with OTC 5% 
Group 2 =  treated with OTC 20% 
Group 3 =  non-treated control      
Means in the same row with the same letter are not significantly different (p>0.05) 
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Weeks Groups 
1 2 3 
Group 1 35.00±0.00b 61.67±4.48a 64.00±4.93a 
Group 2 40.00±10.41b 27.00±9.29a 29.00±10.69a 
Group 3 45.67±3.48a 56.67±6.01a 56.33±6.17a 
Table 4.  Differential count - Neutrophils 
Group 1 =  treated with OTC 5% 
Group 2 =  treated with OTC 20% 
Group 3 =  non-treated control      
Means in the same row with the same letter are not significantly different (p>0.05) 
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Weeks Groups 
1 2 3 
Group 1 57.00±1.53a 36.00±4.16b 33.67±4.98b 
Group 2 51.00±11.59a 71.67±8.82b 69.33±10.68b 
Group 3l 49.33±4.70a 41.00±6.24a 42.00±6.03a 
Table 5.  Differential count - Lymphocytes 
Group 1 =  treated with OTC 5% 
Group 2 =  treated with OTC 20% 
Group 3 =  non-treated control      
Means in the same row with the same letter are not significantly different (p>0.05) 
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Weeks Groups 
1 2 3 
Group 1 1.33±0.33a 1.33±0.33a 2.00±0.00a 
Group 2 1.00±0.58a 1.33±0.33a 1.67±0.33a 
Group 3 1.67±0.33a 1.33±0.33a 1.33±0.33a 
Table 6.  Differential count - Monocytes 
Group 1 =  treated with OTC 5% 
Group 2 =  treated with OTC 20% 
Group 3 =  non-treated control      
Means in the same row with the same letter are not significantly different (p>0.05) 
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Weeks 
 
Groups 
1 2 3 
Group 1 1.00±0.00a 1.00±0.00a 0.33±0.33a 
Group 2 0.33±0.33a 0.33±0.33a 0.33±0.33a 
Group 3 0.67±0.33a 0.67±0.33a 0.67±0.33 
Table 7.  Differential count – Eosinophils  
Group 1 =  treated with OTC 5% 
Group 2 =  treated with OTC 20% 
Group 3 =  non-treated control      
Means in the same row with the same letter are not significantly different (p>0.05) 
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Weeks Groups 
1 2 3 
Group 1 5.67±1.86a 0.33±0.33b 0.00±0.00b 
Group 2 7.67±2.85a 0.33±0.33b 0.00±0.00b 
Group 3 2.67±1.76a 1.00±0.58a 0.33±0.33a 
Group 1 =  treated with OTC 5% 
Group 2 =  treated with OTC 20% 
Group 3 =  non-treated control      
Means in the same row with the same letter are not significantly different (p>0.05) 
Table 8.  Differential count - Basophils 
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Groups Weeks 
 
1 2 3 4 
Group 1 20±3a 20±3a 21.67±3.09a 22.33±2.96a 
Group 2 10.00±1.76a 10.00±1.76a 12.67±1.76a 12.83±1.64a 
Group 3 20.67±3.18a 20.67±3.18a 22.83±4.00a 23.17±4.13a 
Group 1 =  treated with albendazole 2.5% 
Group 2 =  treated with albendazole 5% 
Group 3 =  treated with albendazole 10%    
Means in the same row with the same letter are not significantly 
different (p>0.05) 
Table 9.  Body weight  
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Weeks Groups 
1 2 3 4 
Group 1 11.10±0.47a 10.93±0.52a 11.53±0.64a 11.93±0.52a 
Group 2 8.57±0.61a 8.37±0.99a 8.87±1.08a 9.17±1.09a 
Group 3 8.90±0.47a 9.33±0.33a 9.83±0.34a 10.10±0.35a 
Table 10.  Haemoglobin concentration 
Group 1 =  treated with albendazole 2.5% 
Group 2 =  treated with albendazole 5% 
Group 3 =  treated with albendazole 10%    
Means in the same row with the same letter are not significantly different (p>0.05) 
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Weeks Groups 
1 2 3 4 
Group 1 1233.33±296.27a 0.00±0.00b 0.00±0.00b 0.00±0.00b 
Group 2 1466.67±88.19a 0.00±0.00b 0.00±0.00b 0.00±0.00b 
Group 3 1333.33±133.33a 0.00±0.00b 0.00±0.00b 0.00±0.00b 
Table 11.  Egg count  
Group 1 =  treated with albendazole 2.5% 
Group 2 =  treated with albendazole 5% 
Group 3 =  treated with albendazole 10%    
Means in the same row with the same letter are not significantly different (p>0.05) 
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Figure 1. Body temperature of three groups of experimental animals taken daily. Groups 1 and 2 
were  treated with Oxytetracyline 5% and 20%, respectively  injected intramuscularly and group 3 
were left as non-treated control.  
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Figure 2. Respiratory  rate of three groups of experimental animals taken daily.  Groups 1 and 
2 were  treated with Oxytetracyline 5% and 20%, respectively  injected intramuscularly and 
group 3 were left as non-treated control.  
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Figure  3.  Haemoglobin concentration of three groups of experimental animals estimated 
weekly. Groups 1 and 2 were  treated with Oxytetracyline 5% and 20%, respectively  injected 
intramuscularly and group 3 were left as non-treated control.  
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Figure  4. Differential count of  WBCs – Neutrophils of three groups of experimental animals 
counted weekly. Groups 1 and 2 were  treated with Oxytetracyline 5% and 20%, respectively  
injected intramuscularly and group 3 were left as non-treated control  
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Figure 5. Differential count of  WBCs - Lymphocytess of three groups of experimental animals counted 
weekly.  Groups 1 and 2  were  treated with Oxytetracyline 5% and 20%, respectively  injected 
intramuscularly and group 3 were left as non-treated control  
 
 78
 
 
 
 
 
 
  
0
0.5
1
1.5
2
2.5
Group 1 Group 2 Group 3
%
week 
week 
week 
Figure 6. Differential count of  WBCs - Monocytes of three groups of experimental animals counted 
weekly.  Groups 1 and 2 were  treated with Oxytetracyline 5% and 20%, respectively  injected 
intramuscularly and group 3 were left as non-treated control 
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Figure 7. Differential count of  WBCs - Eosinophils of three groups of experimental animals 
counted weekly. groups 1 and 2  were  treated with Oxytetracyline 5% and 20%, respectively  
injected intramuscularly and Group 3 were left as non-treated control  
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Figure 8.  Differential count of  WBCs - Basophils of three groups of experimental animals counted 
weekly. Groups 1 and 2 were  treated with Oxytetracyline 5% and 20%, respectively  injected 
intramuscularly and group 3 were left as non-treated control  
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Figure 9 .  Body weight of three groups of experimental animals recorded  weekly. 
Group 1  treated with albendazole 2..5%, group 2  treated with albendazole 5% and 
group 3 treated with albendazole 10% orally. 
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Figure 10.   Haemoglobin concentration of three groups of experimental animals examined  weekly
treated with albendazole 2..5%, group 2  treated with albendazole 5% and group 3  treated with alb
orally. 
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Figure 11.  Faecal Egg count of three groups of experimental animals conducted 
weekly. Group 1  treated with albendazole 2..5% Group 2  treated with albendazole 
5% and albendazole 10% orally. 
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Figure12. Necropsy findings. Lung of goat treated with 
oxytetracycline 5%. Note the normal appearance of the lung after 
treatment.  
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Figure13. Necropsy findings. Lung of goat treated with 
oxytetracycline 20%. Note the normal appearance of the lung after 
treatment.  
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Figure14. Necropsy findings. Lung of untreated goat. Note 
the hepatized area in the pneumonic lung 
 
 87
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
Figure 15. Section of lung from goat treated with oxytetracycline 
5%. Note emphysema (a) and thickening of interstitial tissue (b).
H&E  x250. 
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Figure 16. Section of lung from goat treated with oxytetracycline 
5%. Note emphysema (a), interstitial cellular infiltration (b) and 
cuboidal lining of the alveoli (c). H&E x 400 
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Figure 17. Section of lung from goat treated with oxytetracycline 
20%. Note smaller area of emphysema (a) and thickening of 
interstitial tissue ( b). H&E x 100. 
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Figure 18. Section of lung from goat treated with oxytetracycline 
20%. Note emphysema (a), interstitial thickening (b) and 
cuboidal lining of the alveoli (c) H&E x 400. 
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Figure 19.Section of lung from untreated goat. Note the atalatctasis 
(a), cellular infiltration (b) and peribronchial lymphocytic infiltration 
(c). H&E x 250. 
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CHAPTER IV 
Discussion 
Figure  20.Section of lung from untreated goat. Note hyperplastic 
bronchial epithelium (a), cellular exudates of mononuclear cells and 
neutrophils inside the lumen of the bronchus (b). H&E x400. 
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This work is intended to study the efficacies of different 
drugs widely used in the Sudan as well as their economical 
impact. 
Oxytetracycline is a very popular drug and it is used on 
a large scale for many years in the veterinary field in the 
Sudan for treatment of a wide range of animal diseases 
including pneumonia. 
Injectable solution (20%)  a long-acting and a 
conventional (5%) formulations were used in this study to 
treat goats naturally infected with pneumonia caused by 
different types of bacteria and results showed that there was 
significant decrease  in the percentage of  neutrophils in 
weeks 2 and 3 in animals treated oxytetracycline 20%. The 
level of neutrophils was within the normal range as indicated 
by Kelly (1984). This is an indicator for subsidence of the 
infection and the good susceptibility of the causative agents 
to the drug. However, in those treated with oxytetracycline 
5% there was significant increase in percentage of 
neutrophils in weeks 2 and 3 after treatment which indicates 
the lessor response to the drug. 
On the other hand there was significant decrease in 
percentage of lymphocytes in weeks 2 and 3 after treatment 
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with OTC 5% below the normal values range in goats, while 
there was significant increase in percentage of lymphocytes 
in weeks 2 and 3 after treatment with OTC 20% which was 
within the normal values shown by Kelly (1984).The non-
treated control had a low percentage of lymphocytes and a 
high percentage of neutrophils. 
Neutrophilia is caused by many factors, probably the 
most important of which is the infection by pyogenic bacteria. 
In this study pneumonia in goats was caused by pyogenic 
bacteria and this explains why high percentage of neutrophils 
was encountered in those received treatment with OTC 5%. 
This neutrophilia coincided with lymphopenia indicates that 
there was no good response for the drug,  in contrast to the 
good response showed by animals which received treatment 
with OTC 20% in which normal percentages of neutrophils 
and lymphocytes were within the normal range. 
In both drug formulations there was significant 
decrease in the percentage of basophils in weeks 2 and 3 
after treatment in animals treated with oxytetracycline 5% 
and oxytratracycline 20%. According to Kelly (1984) 
basophils are rare in all animal species comprising about 
0.2%of the total leucocyte population and their role is to 
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release heparin and histamine when there is tissue injury 
thereby initiating an inflammatory reaction. This explains the 
reduction in the high percentage of basophils in both groups 
after treatment. 
Histopathological findings from sections of lungs taken 
at necropsy from animals treated with OTC 5% showed large 
areas of emphysema and infiltration with mononuclear cells 
in the interstitial tissues, while those taken from animals 
treated with OTC 20% showed smaller areas of emphysema. 
In both groups some alveoli showed cuboid form of 
epithelium indicating that there had been tissue damage and 
then repair took place. 
These results demonstrate that OTC was effective in 
treating natural infection with pneumonia as determined by 
allevation of clinical signs, pathological findings at 
postmortem and presence of viable bacteria from the lungs. 
This was also reported by Morck, et.al (1997). 
During the second week after treatment with OTC 5% 
animals still showed irregular respiration, scanty nasal 
discharge and no cough while animals treated with OTC 20% 
showed regular respiration, scanty nasal discharge and no 
cough. During week 3 after treatment the clinical picture 
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remained as it is among animals treated with oxytetracycline 
5%, while animals treated with oxytetracycline 20% showed 
progress by disappearance of the nasal discharge in 
comparison with the non-treated control which showed 
irregular respiration, mucoid nasal discharge and cough.  
This leads to the conclusion that animals treated with OTC 
20% showed progress and subsidence of clinical signs better 
than those treated with OTC 5%.Similar results were 
obtained by Weikel and Graunke (1995). 
Results obtained in this study concluded that OTC 20% 
long-acting formulation was more efficacious in treating 
natural infection with pneumonia in goats than the 
conventional formulation OTC 5%.This may be attributed to 
the more sustained serum concentration and longer mean 
residence times and complete bioavailability of the long-
acting formulation in comparison with the conventional 
formulation as reported by Banting and Baggot (1996), 
Davey, et.al (1985) and Escudero, et.al (1994).However, 
some studies conducted by Swant, et.al (2007), 
Khachatrryan, et.al (2006), Blanco, et.al (2006), Chopra and 
Roberts (2001) and Shearer and Hernandez (2000) revealed 
some evidence of resistance to oxytetracycline.  
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Albendazole is also a popular and widely used 
anthelmintic in the veterinary field in the Sudan. Our results 
showed although no significant increase, but better weights 
were revealed in animals which received treatment with 
albendazole 2.5%, albendazole 5% and albendazole 10% 
indicating that the effect on nematode infections was 
reflected in better weight gains post treatment. This similar to 
the findings of Boa, et.al (2001) who used albendazole for 
treatment of ewes and lambs infected with internal parasites. 
The results showed a highly significant reduction in egg 
count per gram of faeces in all groups reaching 100% 7 days 
post-treatment indicating that albendazole is highly 
efficacious in removing nematode burden. Relative results 
were obtained by Biorn, et.al (1990) who conducted a study 
on gastrointestinal nematodes of sheep and goats treated 
with albendazole at 3.8 mg/kg, They found 94.3% reduction 
in faecal egg count 7 days post-treatment. Also Echevarria, 
et.al (1991) reported that albendazole reduced egg count by 
92.5% on day 7 post-treatment in sheep infected with 
Haemonchus contortus strain resistant to ivermectin in 
Brazil. 
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However, many reports and studies showed that many 
gastrointestinal nematodes has developed resistance to 
albendazole (Yadav,et.al, 1995, Waruiru,1997 and Sissay, 
et.al, 2006). 
The haemoglobin concentration was increased but not 
significant after treatment among the three concentrations of 
albendazole 15 days post-treatment. This may be due to the 
removal of parasitic populations which cause anaemia due to 
reduced food intake and decreased food utilization and 
competition with the host for food as stated by Soulsby 
(1986). 
Due to the impact of the dairy quota system, the 
commercial use of goats for the production of milk and 
associated products is attractive to farmers diversifying their 
interest, intensification of milking and the expansion of herds 
will inevitably increase the incidence of caprine mastitis.  
Mastitis is a common problem facing dairy herds and 
causes substantial economic losses in form of decreased 
milk production and cost of different drugs purchased for 
treatment. Neomastipra and terrexine intramammary 
infusions are widely used in the veterinary field and they are 
intended for treatment of bovine mastitis.  Their efficacies 
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against Actinomyces pyogenes one of the causes of mastitis 
beside other pyogenic infections in various domestic animals 
as reported by Coyle and Lipsky (1990) have been evaluated 
in this study. Treatment course with neomastipra and 
terrexine extended for 5 consecutive days. Results revealed 
inhibition of the growth of the microorganism 10 days post-
treatment. This indicated the good treatment response with 
these products and there was no significant difference 
between the two antibiotics. Similar results were obtained by 
Mc Dougall (1998). 
These results disagrees with Merle, et.al (2002) who 
stated that infections caused by A. pyogenes require 
prolonged antimicrobial therapy and are frequently 
unresponsive to treatment. However, the pharmaceutical 
industry and the veterinary surgeon will be required to 
provide data and advise upon performance of currently 
available bovine intramammary products if used in goats. 
Buswell, et.al (1989) produced evidence that one available 
bovine intramammary product when infused into the glands 
of milking goat produce a withholding time approximately 
double that defined for the cow. 
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Regarding the economical impact of these drugs used 
in this study, it was found that the total cost of treating a 
single animal with oxytetracycline 5% is 50 SDG while the 
cost when it is treated with oxytetracycline 20% is 24 SDG . 
This indicates that treatment with oxytetracycline 20% is 
cheaper than using oxytetracycline 5%. In addition to that 
treatment with oxytetracycline 5% is time consuming (5 days) 
while treatment with oxytetracycline 20% is only one day. 
In the treatment of internal parasites using different 
concentrations of albendazole 2.5%, 5% and 10% it was 
found that treatment with albendazole10%  is more cheaper 
costing 30 SDG per animal than other concentrations which 
cost 90 SDG for albendazole 2.5% and 60 SDG for 
albendazole 5%. 
In case of treatment of mastitis it was found that the 
single dose of neomastipra cost 2.5 SDG and that of 
terrexine cost 3.5 SDG indicating that treatment with 
neomastipra intramammary infusion is cheaper than 
treatment with terrexine intramammary infusion. 
Conclusions and recommendations 
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1. This study is considered to be the first authentic study for the 
evaluation of the drugs commonly used on the veterinary 
field in the Sudan (antibiotics and anthelmintics). 
2. This study showed that the use of oxytetracycline 20% 
should be encouraged and at the same time the use of 
oxytetracycline 5% should be disclosed. 
3. This study also showed that the use of higher concentrations 
of anthelmintics should be encouraged because it is more 
economic and efficient and can eradicate and control the 
internal parasites on a  regular intensive programmes. 
4. At the same time the treatment of mastitis with the available 
drugs should be coupled with injectable antibiotics of the 
same type and drugs with more than one component should 
be preferred. 
5. Further studies should be conducted to point out the exact 
withdrawal periods of these drugs. 
6. Continuous and regular studies should be conducted to 
evaluate the efficacies of these drugs and other drugs in use 
in the veterinary field in the Sudan since resistance has been 
developed to many of them worldwide. 
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